Pre-eclampsia: the Potential of GSNO Reductase Inhibitors

PURPOSE OF REVIEW: Pre-eclampsia remains a leading worldwide cause of maternal death and of perinatal morbidity. There remains no definitive treatment except delivery of the fetus. RECENT FINDINGS: Recent insights into the cardiovascular changes that are evident prior to, during, and persist after p...

Descripción completa

Detalles Bibliográficos
Autores principales: Everett, Thomas R., Wilkinson, Ian B., Lees, Christoph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Preeclampsia (VD Garovic, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340829/
https://www.ncbi.nlm.nih.gov/pubmed/28271419
http://dx.doi.org/10.1007/s11906-017-0717-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340829/
https://www.ncbi.nlm.nih.gov/pubmed/28271419
http://dx.doi.org/10.1007/s11906-017-0717-2

Ejemplares similares